CEO: | Stephen O'Hara |
Finance Director: | Graham Myers |
Non-Executive Chairman: | Neil Davidson |
Research and Development Director: | Sofia Kolyda |
Non-Executive Dir: | Sean Christie |
Address: | 145-147 St John Street, London, EC1V 4PY |
Phone: | + 44 (0) 203 178 5618 |
Website: | http://www.optibiotix.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BP0RTP38 |
Currency | UK Pounds |
Share Price | 19.60p |
Change Today | -1.40p |
% Change | -6.67 % |
52 Week High | 39.00 |
52 Week Low | 6.00 |
Volume | 572,429 |
Shares Issued | 97.94m |
Market Cap | £19.20m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 349 @ 20.00p |
16:35 | 97 @ 20.50p |
16:35 | 19 @ 20.00p |
16:35 | 1,482 @ 19.60p |
16:35 | 1,482 @ 19.60p |
CEO | Stephen O'Hara |
Finance Director | Graham Myers |
You are here: research